Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Derivatives in MRNA
reported options exposure · as of Mar 31, 2026CallValue
$16,596,360
CallShares
326,700
PutValue
$27,635,200
PutShares
544,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Alphadyne Asset Management LP holds $5,118,929 across 5 Biotechnology names.
All Filings in MRNA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,596,360 | 326,700 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $27,635,200 | 544,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $4,426,449 | 150,100 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $4,907,136 | 166,400 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $485,604 | 18,800 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $795,564 | 30,800 | Call | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||